SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY

This adverse event was reported 407 times

SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ACITRETIN 21 0.0043
1 DATOPOTAMAB DERUXTECAN 2 0.0023
2 MARAVIROC 2 0.0009
3 BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE 2 0.0009
4 AXICABTAGENE CILOLEUCEL 8 0.0008
5 HUMAN IMMUNOGLOBULIN G 16 0.0008
6 PENTOXIFYLLINE 3 0.0007
7 LECANEMAB 2 0.0005
8 ITRACONAZOLE 6 0.0005
9 RALTEGRAVIR 2 0.0004
See all drugs enriched for association with SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY